Optimizing Pulsatility During Cardiopulmonary Bypass
Recruiting
Observational Study
Endothelial Dysfunction
Acute Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 66 (estimated)
- Sponsor
- University of Colorado, Denver · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cardiopulmonary bypass during cardiac surgery provides blood flow to the body during surgery but has adverse effects on different organs. Blood flow during cardiopulmonary bypass may be pulsatile or non-pulsatile, which may impact normal organ function after surgery. The study will collect data on the type of cardiopulmonary bypass used during surgery and organ function to determine if there is an…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 50 to 70
* Able to provide informed consent
* Scheduled for elective cardiac surgery with cardiopulmonary bypass
Exclusion Criteria:
* Patients undergoing emergency procedures
* Diagnosed with sepsis
* Experiencing delirium
* Experiencing hemodynamic instability (heart r…
Contacts